Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abivax
Biotech
Abivax stock rebounds on colitis prospect safety data
Abivax has recovered from a dent in its share price after unveiling fresh safety data that appeared to ease investors' concerns.
James Waldron
Jun 30, 2026 10:27am
Abivax stock suffers as cancer cases overshadow stellar efficacy
Jun 2, 2026 5:30am
Tang takes over Aurinia after FDA brouhaha—Chutes & Ladders
Mar 27, 2026 11:05am
Abivax aces phase 3 colitis trials as end of cash runway looms
Jul 23, 2025 6:30am
Two biotechs go public while Apnimed bides its time
Oct 2, 2023 11:02am
Oncorus C-suite out the door—Chutes & Ladders
Jun 9, 2023 9:30am
